🇺🇸 FDA
Patent

US 8084630

Process for the synthesis of ramelteon and its intermediates

granted A61PA61P43/00

Quick answer

US patent 8084630 (Process for the synthesis of ramelteon and its intermediates) held by TEVA PHARMACEUTICAL INDUSTRIES, LTD. expires Mon Dec 22 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
TEVA PHARMACEUTICAL INDUSTRIES, LTD.
Grant date
Tue Dec 27 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 22 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
31
CPC classes
A61P, A61P43/00